[Clinical experiences with gerontotherapeutic agent Wallerox (GN 468)].
D000368:Aged; D001921:Brain / Q000098:blood supply; D002018:Bufanolides / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use*; D012917:Social Adjustment / Q000187:drug effects; D013806:Theophylline / Q000627:therapeutic use*
D002018:Bufanolides; D009539:Nicotinic Acids; D004877:Ergoloid Mesylates; D013806:Theophylline
Klinische Erfahrungen mit dem Gerontotherapeutikum Wallerox (GN 468.